Consistent with other reports in the literature (22, 43, 56), we confirm here that NKG2D-ligands are frequently expressed in primary AML and T-ALL and demonstrate robust NKG2D-ligand expression in different AML and T-ALL cell lines. This evidence concerns the gene KLRK1 and acute myeloid leukemia.